Treatment of MEN Type 2A with Brain Metastases of Medullary Thyroid Carcinoma and Neurologic Symptoms

This protocol covers the management of Multiple endocrine neoplasia type 2A (MEN2A) when medullary thyroid carcinoma has spread to the brain, producing neurologic symptoms. The presence of central nervous system involvement fundamentally shapes the treatment approach and requires prompt evaluation.

Clinical Scenario

Central nervous system metastases

Patients with widespread metastases and neurological symptoms should be evaluated for the presence of brain metastases. Once confirmed, the extent of intracranial involvement — isolated versus multiple lesions — is the key factor that determines which local intervention is appropriate.

Treatment Approach (partial overview)

Management of brain metastases in this setting centres on targeted local interventions. Radiation-based strategies are a cornerstone of care, with the specific modality and scope determined by disease distribution. The full structured protocol details the complete decision algorithm and the conditions under which each option applies.

Complete regimen, sequencing, and indications available via the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1089/thy.2014.0335

Patients with widespread metastases and neurological symptoms should be evaluated for the presence of brain metastases.

Patients with isolated brain metastases are candidates for surgical resection or EBRT (including stereotactic radiosurgery).

Whole-brain EBRT is indicated for multiple brain metastasis.

View source ↗